Morpheus8 is an advanced radiofrequency microneedling treatment that combines fractional RF energy with microneedling to stimulate collagen remodeling deep within the skin and subdermal tissue. Widely recognized as one of the leading non-surgical skin tightening treatments available today, Morpheus8 improves skin firmness, texture, contour, and overall skin quality in a way that surface-level treatments cannot replicate.
At GhalMédica in Pointe-Claire, Morpheus8 treatments are performed personally by Dr. Sonya Ghalehii, MD, Medical Director. The technology is particularly effective for skin laxity, loss of jawline definition, textural irregularities, acne scarring, and the structural changes associated with aging, perimenopause, and menopause. Every treatment begins with a physician assessment to evaluate skin quality, facial anatomy, depth of concern, and treatment goals before a customized protocol is developed.
The safety and effectiveness of Morpheus8 depend significantly on proper device calibration and treatment depth. At GhalMédica, Fitzpatrick skin type assessment precedes every Morpheus8 treatment to minimize the risk of post-inflammatory hyperpigmentation and optimize outcomes across a wide range of skin tones. Treatment parameters are individualized, never standardized.
GhalMédica serves patients from Pointe-Claire, Kirkland, Beaconsfield, Dollard-des-Ormeaux, Dorval, Vaudreuil, and the greater Montreal area seeking physician-led skin tightening and collagen remodeling treatments. Morpheus8 is frequently incorporated into the GhalMédica InvisiLift™ approach alongside SkinBoosters for patients seeking a comprehensive strategy to improve skin quality, facial definition, and age-related tissue laxity.
Treatment time is approximately 45 to 60 minutes. Downtime of 2 to 5 days is typical, with redness and mild swelling in the immediate post-treatment period. Results develop progressively over 3 to 6 months as collagen remodeling occurs.
Results vary. A physician consultation is required prior to treatment.
Book a ConsultationResults vary by patient.
Morpheus8 is a device. The outcome depends entirely on how the physician uses it. Needle depth, RF energy level, pulse duration, and pass sequencing are all variables that must be set based on the patient's Fitzpatrick skin type, the depth of the concern being treated, and the area of the face. A standardized Morpheus8 protocol is not a clinical protocol. It is a liability.
Fitzpatrick Assessment First
Every Morpheus8 patient at GhalMedica is assessed using the Fitzpatrick scale before treatment begins. This determines the safe energy range for your skin tone and guides parameter selection throughout the protocol.
Individualized Depth Calibration
Needle depth and RF energy are calibrated based on the concern being addressed. Skin laxity requires different parameters than textural irregularity. The face and neck require different settings than the body. Nothing is standardized.
Physician-Administered
All Morpheus8 treatments at GhalMedica are performed personally by Dr. Sonya Ghalehii, MD. The physician assesses, plans, and performs the treatment at every session, not only the first consultation.
Progressive Protocol
Results from Morpheus8 build over three to six months as collagen remodelling occurs. A full series of three sessions is recommended before results are assessed. Each session builds on the tissue response from the previous one.
Avoid prolonged sun exposure and tanning — including self-tanning products and tanning beds. Tanned or sunburned skin significantly increases the risk of post-inflammatory hyperpigmentation following radiofrequency microneedling. Sun protection is essential in the weeks leading up to treatment.
Discontinue retinoids, tretinoin, and high-strength exfoliating acids — including AHAs and BHAs — as directed by your practitioner. These products increase skin sensitivity and can compromise the skin barrier ahead of treatment.
Avoid blood-thinning medications and supplements where medically appropriate, including aspirin, ibuprofen, vitamin E, and fish oil. Avoid alcohol for at least 24 hours prior to your appointment.
Arrive with thoroughly clean skin — no makeup, moisturizer, sunscreen, or active skincare on the treatment area. A topical numbing cream will be applied at the clinic prior to treatment. Wear comfortable clothing that does not need to be pulled over your face.
Pre-treatment instructions are based on Canadian dermatology and aesthetic medicine best practices. Individual instructions may vary — your GhalMédica practitioner will provide personalized guidance at consultation.
Expect redness, warmth, and mild swelling — this is a normal inflammatory response and part of the healing process. Do not apply makeup, active skincare products, or anything other than the gentle, fragrance-free products recommended by your practitioner. Keep the skin cool and clean.
Avoid strenuous exercise, saunas, steam rooms, swimming, and any activity that causes significant perspiration. Avoid direct sun exposure entirely. Do not pick, scratch, or exfoliate the treated area — skin will feel rough and may appear bronzed or slightly crusted as it heals.
Reintroduce active skincare products gradually and only as directed by your practitioner. Apply broad-spectrum SPF 30 or higher every morning without exception — UV exposure on healing skin significantly increases the risk of post-inflammatory hyperpigmentation.
Results from Morpheus8 develop over 3 to 6 months as the collagen remodeling process progresses. Do not assess final outcomes before this window. Maintain daily SPF use. A series of treatments is often recommended for optimal results — your practitioner will advise on timing at your follow-up appointment.
Post-treatment instructions are based on Canadian dermatology and aesthetic medicine best practices. If you experience severe pain, blistering, or unusual skin changes following treatment, contact GhalMédica promptly.
A topical numbing cream is applied prior to treatment to minimize discomfort. Most patients describe the sensation as a warm pressure or mild prickling. Deeper settings used for subdermal remodeling may be more intense in certain areas. Your comfort is actively managed throughout the procedure and your practitioner will adjust as needed.
Many patients maintain results for one to two years after a full series. Regular maintenance sessions can extend and sustain the improvement.
Morpheus8 combines radiofrequency energy with microneedling, reaching the dermis and subdermal tissue for structural remodelling and laxity improvement. SkinPen is a mechanical microneedling device that stimulates collagen through controlled micro-injuries without RF energy. Morpheus8 produces more significant tightening and lifting. SkinPen is effective for texture, tone, and mild scarring at a shorter recovery time.
Most patients experience 2 to 5 days of visible redness, swelling, and a bronzed or rough texture to the skin as it heals. The majority of visible downtime resolves within a week, though skin may continue to feel slightly sensitive for up to two weeks. Planning treatment around social commitments is advisable.
Morpheus8 is one of the few radiofrequency microneedling devices considered safe across a broad range of skin types, including darker skin tones, because the energy is delivered via needles into the dermis rather than targeting surface melanin. However, treatment parameters must be carefully calibrated for each patient — at GhalMédica, this assessment is made at consultation by Dr. Sonya Ghalehii, MD.
Dr. Ghalehii typically recommends three sessions spaced four to six weeks apart. A physician consultation determines the appropriate number for your skin condition and goals.
GhalMédica offers physician-administered Morpheus8 at 330 Ch. du Bord-du-Lac-Lakeshore, Pointe-Claire. All treatments are performed personally by Dr. Sonya Ghalehii, MD. We serve Pointe-Claire, Kirkland, Beaconsfield, Dollard-des-Ormeaux, Vaudreuil, Dorval, and the greater Montreal area.
with a consultation.
Dr. Sonya Ghalehii, MD will assess your skin, understand your concerns, and recommend a treatment path built around you — not a menu.
